Abstract
Background: The Cambodia-Thai border area has been the epienter ofmalaria parasite resistance to various anti-malarial drugs. he USAID Malaria Control Project in Cambodia implemented by niversity Research Co., LLC and other partners with funding from HO conducted a pilot study of community day-3 surveillance of lasmodium falciparum parasite in two health centers catchment reas from September 2010 to November 2011. Village Malaria orkers (VMWs) play very crucial role in providing an early iagnosis and appropriate treatment in their community. VMWs ere asked to play an additional role in smear making and direct bserved therapy. Methods: Fifty-six VMWswere trained on the use of rapid diagostic tests (RDT) for all suspectedmalaria cases, smearmaking for onfirmed P. falciparum, and malaria treatment. Health center staff rganized a regular monthly meeting of VMWs at the health cener to share information and distribute supplies such as RDTs and rtemisinin combination therapy to the VMWs. For each confirmed . falciparum case, the VMWs did two smears on Day 0 and Day and sent the slides to the health center laboratory for reading. MWs provided direct observed therapy for all enrolled malaria ases. Travel and treatment historieswere recordedbyVMWs.Data n all Day-3 positive cases was sent by SMS to staff at the district nd central levels for further investigation. Results: VMWs enrolled 264 P. falciparum and 24 P. falciparum lus P. vivax cases in the surveillance. Three-quarters (76%) of ases were male, mostly between 15-49 years. One quarter (24%) ere mobile and migrant workers. Fifty-six of 288 enrolled cases emained positive on Day-3 (17%) and received further investiation and treatment. An external evaluation supported by WHO ound the quality of VMW diagnosis and treatment to be of high uality. Conclusion:Theuseof communityvolunteers forDay-3 surveilance is feasible and can have high quality results. This pilot proves hat Day-3 positivity, an early warning sign of potential multi-drug esistance, can be captured at community level.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
